Published in Clin Breast Cancer on June 01, 2006
Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients. Cancer (2009) 2.63
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. Arch Pathol Lab Med (2013) 2.54
Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype. Breast Cancer Res (2013) 1.05
HER-2/neu diagnostics in breast cancer. Breast Cancer Res (2007) 1.04
Highly sensitive proximity mediated immunoassay reveals HER2 status conversion in the circulating tumor cells of metastatic breast cancer patients. Proteome Sci (2011) 0.98
Current Challenges for HER2 Testing in Diagnostic Pathology: State of the Art and Controversial Issues. Front Oncol (2013) 0.95
HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens. BMC Cancer (2010) 0.92
Importance of formalin fixing conditions for HER2 testing in gastric cancer: immunohistochemical staining and fluorescence in situ hybridization. Gastric Cancer (2014) 0.87
Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program. Breast Cancer Res Treat (2012) 0.86
A single-tube quantitative assay for mRNA levels of hormonal and growth factor receptors in breast cancer specimens. J Mol Diagn (2009) 0.84
Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer. Cancer (2014) 0.82
Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay. PLoS One (2016) 0.81
Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification. Breast Cancer Res (2016) 0.80
A novel quantitative immunohistochemistry method for precise protein measurements directly in formalin-fixed, paraffin-embedded specimens: analytical performance measuring HER2. Mod Pathol (2016) 0.77
Gene expression profiling in breast cancer. Am J Transl Res (2013) 0.77
Evaluation of chromosome 17 polysomy in breast cancer by FISH analysis of whole nuclei, and its clinicopathological significance. Oncol Lett (2014) 0.77
An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer. Virchows Arch (2016) 0.77
Determination of the HER2 amplification status by in situ fluorescent hybridization and concordance with immunohistochemistry for breast cancer samples in Colombia. Colomb Med (Cali) (2013) 0.75
SHOULD FISH TEST BE PERFORMED TO ALL PATIENTS WITH BREAST CANCER? Med Sci (Turkey) (2013) 0.75
Human epidermal growth factor receptor 2 expression in breast cancer: correlation with clinical pathological features. Int J Clin Exp Pathol (2014) 0.75
Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases. J Transl Med (2017) 0.75
Free digital image analysis software helps to resolve equivocal scores in HER2 immunohistochemistry. Virchows Arch (2015) 0.75
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med (2005) 33.60
Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer. J Clin Oncol (2005) 5.27
Genotype-guided tamoxifen dosing increases active metabolite exposure in women with reduced CYP2D6 metabolism: a multicenter study. J Clin Oncol (2011) 2.47
A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer. Semin Oncol (2003) 2.23
Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations. J Biol Chem (2004) 1.69
Suppression of apoptosis in the protein kinase Cdelta null mouse in vivo. J Biol Chem (2006) 1.61
Metabolic regulation in the lactating mammary gland: a lipid synthesizing machine. Physiol Genomics (2006) 1.61
Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b. Horm Cancer (2014) 1.55
Sugar and fat - that's where it's at: metabolic changes in tumors. Breast Cancer Res (2008) 1.49
Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration. Ophthalmology (2005) 1.47
Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo. PLoS One (2011) 1.43
Expression of constitutively activated Akt in the mammary gland leads to excess lipid synthesis during pregnancy and lactation. J Lipid Res (2003) 1.41
Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer. Breast Cancer Res Treat (2008) 1.32
Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer. Clin Cancer Res (2011) 1.31
MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src. Mol Cell Biol (2003) 1.29
Inhibition of Src family kinases blocks epidermal growth factor (EGF)-induced activation of Akt, phosphorylation of c-Cbl, and ubiquitination of the EGF receptor. J Biol Chem (2002) 1.28
MDM2 is required for suppression of apoptosis by activated Akt1 in salivary acinar cells. Mol Cell Biol (2006) 1.23
Suppression of radiation-induced salivary gland dysfunction by IGF-1. PLoS One (2009) 1.21
Lipid synthesis in lactation: diet and the fatty acid switch. J Mammary Gland Biol Neoplasia (2007) 1.15
Analysis of lactation defects in transgenic mice. J Mammary Gland Biol Neoplasia (2006) 1.08
Sterol regulatory element binding protein and dietary lipid regulation of fatty acid synthesis in the mammary epithelium. Am J Physiol Endocrinol Metab (2010) 1.02
Heart rate multiscale entropy at three hours predicts hospital mortality in 3,154 trauma patients. Shock (2008) 1.01
Development of a cathartic-free colorectal cancer screening test using virtual colonoscopy: a feasibility study. AJR Am J Roentgenol (2007) 1.01
Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells. Mol Endocrinol (2006) 0.97
Adipose-depleted mammary epithelial cells and organoids. J Mammary Gland Biol Neoplasia (2009) 0.94
Inducible overexpression of GLUT1 prevents mitochondrial dysfunction and attenuates structural remodeling in pressure overload but does not prevent left ventricular dysfunction. J Am Heart Assoc (2013) 0.93
Obesity and overfeeding affecting both tumor and systemic metabolism activates the progesterone receptor to contribute to postmenopausal breast cancer. Cancer Res (2012) 0.93
AKT regulates BRCA1 stability in response to hormone signaling. Mol Cell Endocrinol (2010) 0.91
Lactation and neonatal nutrition: defining and refining the critical questions. J Mammary Gland Biol Neoplasia (2012) 0.89
Regulation of the Pro-apoptotic scaffolding protein POSH by Akt. J Biol Chem (2007) 0.88
Lactation failure in Src knockout mice is due to impaired secretory activation. BMC Dev Biol (2008) 0.88
Formyl-Met-Leu-Phe induces calcium-dependent tyrosine phosphorylation of Rel-1 in neutrophils. Cell Calcium (2003) 0.87
Activated Akt1 accelerates MMTV-c-ErbB2 mammary tumourigenesis in mice without activation of ErbB3. Breast Cancer Res (2008) 0.85
Stat5 regulates the phosphatidylinositol 3-kinase/Akt1 pathway during mammary gland development and tumorigenesis. Mol Cell Biol (2014) 0.84
Characterization of rat parotid and submandibular acinar cell apoptosis in primary culture. In Vitro Cell Dev Biol Anim (2003) 0.84
Prolactin-mediated regulation of lipid biosynthesis genes in vivo in the lactating mammary epithelial cell. Am J Physiol Endocrinol Metab (2011) 0.83
Inhibiting tyrosine phosphorylation of protein kinase Cδ (PKCδ) protects the salivary gland from radiation damage. J Biol Chem (2014) 0.81
The insulin receptor plays an important role in secretory differentiation in the mammary gland. Am J Physiol Endocrinol Metab (2013) 0.79
Rah, rah, ROS: metabolic changes caused by loss of adhesion induce cell death. Breast Cancer Res (2009) 0.77
Development of the breast cancer education and risk assessment program. Oncol Nurs Forum (2003) 0.76
FASNating targets of metformin in breast cancer stem-like cells. Horm Cancer (2014) 0.75